Finasteride (10 Offers)

What Is Finasteride?

Finasteride is a prescription medicine belonging to the 5-alpha-reductase inhibitor class. It reduces the enzymatic conversion of testosterone into dihydrotestosterone (DHT), an androgen involved in tissues including the prostate and hair follicles.

Finasteride is not an anabolic-androgenic steroid and does not function as an androgen-receptor blocker. Instead, its primary mechanism involves altering androgen metabolism by inhibiting 5-alpha-reductase and thereby reducing DHT formation.

Finasteride, 5-Alpha-Reductase & DHT

The enzyme 5-alpha-reductase converts testosterone into DHT. Finasteride primarily inhibits the type II isoenzyme, resulting in reduced DHT formation in tissues where this pathway is active.

DHT is a potent androgen involved in normal physiology as well as androgen-dependent processes such as prostate growth and androgenetic hair loss in genetically susceptible individuals.

Reducing DHT should therefore not be confused with blocking testosterone itself. Finasteride modifies a specific metabolic pathway rather than broadly preventing all androgen activity.

Finasteride vs. Dutasteride

Finasteride and Dutasteride belong to the same general class of 5-alpha-reductase inhibitors, but they are separate medicines with important pharmacological differences.

Finasteride primarily inhibits type II 5-alpha-reductase. Dutasteride inhibits both type I and type II 5-alpha-reductase and generally produces a greater reduction in circulating DHT.

The two medicines also differ substantially in pharmacokinetics. Dutasteride has a considerably longer elimination half-life, while Finasteride is cleared more rapidly.

These differences do not mean that one product is automatically appropriate whenever the other is considered. Their approved uses, individual response and clinical context should be considered separately.

Finasteride vs. Aromatase Inhibitors

Finasteride should not be confused with aromatase inhibitors such as Anastrozole or Exemestane. Both categories influence hormone metabolism, but they target different enzymes and different conversion pathways.

Finasteride inhibits 5-alpha-reductase and reduces the conversion of testosterone to DHT. Aromatase inhibitors reduce estrogen synthesis by inhibiting the aromatase enzyme.

Reducing DHT and reducing estrogen are therefore different pharmacological effects, and these drug classes should not be treated as interchangeable ancillary products.

Comparing Finasteride Products

When browsing Finasteride products, useful comparison points include the labeled amount per tablet, total tablet count, manufacturer, current price, warehouse location and published laboratory testing where available.

Products containing the same active ingredient can still differ in tablet strength, package quantity and manufacturer-specific branding. Reviewing the complete product specification provides a clearer comparison than relying on price or package appearance alone.

Tablet Strength vs. Package Quantity

The labeled mg-per-tablet strength identifies the amount of Finasteride stated in each tablet. Package quantity separately identifies the total number of tablets supplied.

Two Finasteride products can therefore contain the same active ingredient while differing in tablet strength or package quantity. Check both specifications when comparing available products.

Published Finasteride Lab Reports

Selected Finasteride products may have published laboratory reports that provide an additional reference point when comparing the labeled specification with the measured result reported for a submitted sample.

Where testing is available, review the identified active substance, measured result, testing date and reported batch number. If multiple reports have been published, results from different testing dates or batches can be reviewed individually.

Each laboratory report applies to the submitted sample identified in that analysis. A result from one sample does not independently verify every tablet, package or future production batch.

Finasteride & Male-Pattern Hair Loss

DHT plays an important role in androgenetic alopecia, commonly known as male-pattern hair loss, in genetically susceptible individuals. Finasteride's ability to reduce DHT is the basis for its established use in this context.

Androgenetic alopecia involves progressive miniaturization of susceptible hair follicles. However, not every form of hair loss is androgenetic, and reducing DHT does not guarantee the same response for every individual.

Determining the underlying cause of hair loss is therefore important rather than assuming that every change in hair density represents a DHT-related condition.

Finasteride & Benign Prostatic Hyperplasia

Finasteride also has an established medical role in the management of benign prostatic hyperplasia (BPH). BPH involves noncancerous enlargement of the prostate and becomes increasingly common with age.

By reducing DHT formation, Finasteride can reduce androgenic stimulation of prostate tissue. Its clinical use for BPH is based on appropriate diagnosis and medical assessment rather than DHT reduction being pursued as an objective by itself.

Different Finasteride indications can involve different product strengths and clinical considerations, which is another reason the exact product specification should be checked rather than treating all Finasteride products as identical.

Finasteride & Anabolic Steroid Context

Finasteride is sometimes discussed alongside anabolic-androgenic steroids because certain androgens can undergo 5-alpha reduction and because DHT is associated with androgen-sensitive tissues such as the scalp and prostate.

However, Finasteride should not be viewed as a universal blocker of steroid-related androgenic effects. Its mechanism specifically involves inhibition of 5-alpha-reductase, and anabolic compounds differ substantially in their metabolism.

Some anabolic-androgenic steroids are already DHT-derived or do not depend on conversion through 5-alpha-reductase for their androgenic activity. In those cases, inhibiting testosterone-to-DHT conversion does not simply neutralize the androgenic properties of the other compound.

For that reason, this category provides information about Finasteride and available products rather than recommending steroid combinations or ancillary-use protocols.

Finasteride Safety Information

Finasteride is a pharmacologically active prescription medicine and can cause clinically significant adverse effects. Reported effects can include changes in libido, erectile or ejaculatory function and other sexual or reproductive effects.

Mood-related adverse effects have also been reported. New or concerning physical or psychological symptoms during treatment warrant appropriate medical evaluation.

Finasteride also reduces prostate-specific antigen (PSA) levels. This is important because PSA measurements may be used as part of prostate evaluation, and healthcare professionals interpreting PSA results should know about Finasteride use.

Pregnancy-related handling precautions are important because exposure to Finasteride can pose a risk to the development of a male fetus. Product-specific prescribing and handling information should be followed.

A published laboratory report can provide information about the analyzed product sample but does not establish that taking Finasteride is medically appropriate for an individual. This category is intended for product identification and comparison and does not provide individualized dosing or treatment protocols.

Does Finasteride Block Testosterone?

Finasteride does not work by blocking testosterone receptors or eliminating testosterone. Its primary action is inhibition of 5-alpha-reductase, which reduces the conversion of testosterone into DHT.

This distinction is important when comparing Finasteride with antiandrogens or other hormone-related medicines. A lower DHT level does not mean that all androgen signaling has been suppressed.

USA Domestic & International Availability

Finasteride products may be available from the USA Domestic Warehouse, the International Warehouse, or both. Available manufacturers, tablet strengths and stock levels can differ between warehouse locations.

For delivery within the United States, USA Domestic shipments typically take 4–5 business days after dispatch, while International Warehouse shipments typically take 15–20 business days after dispatch.

Delivery estimates begin after dispatch and do not include order processing time. Additional delivery, tracking and reship information is available on the Shipping Information page.

Ordering & Crypto Payment

Bitcoin and other supported cryptocurrencies are available at checkout. When comparing Finasteride products, review the manufacturer, labeled tablet strength, package quantity, current price, available laboratory reports and warehouse location.

Where the store's separate crypto discount applies, eligibility depends on the current pricing status of the product. Already discounted products should not automatically be assumed to qualify for an additional discount.